Published in PLoS One on March 02, 2011
The role of mycelium production and a MAPK-mediated immune response in the C. elegans-Fusarium model system. Med Mycol (2012) 0.79
Potent Inhibition of Pseudogymnoascus destructans, the Causative Agent of White-Nose Syndrome in Bats, by Cold-Pressed, Terpeneless, Valencia Orange Oil. PLoS One (2016) 0.75
In vitro investigation of a terbinafine impregnated subcutaneous implant for veterinary use. J Drug Deliv (2012) 0.75
An emerging disease causes regional population collapse of a common North American bat species. Science (2010) 6.88
Bat white-nose syndrome: an emerging fungal pathogen? Science (2008) 6.32
Pathogenesis of chytridiomycosis, a cause of catastrophic amphibian declines. Science (2009) 4.45
In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother (2001) 3.28
EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect (2008) 3.01
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev Iberoam Micol (2003) 2.45
Morphological and molecular characterizations of psychrophilic fungus Geomyces destructans from New York bats with White Nose Syndrome (WNS). PLoS One (2010) 1.91
High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proc Natl Acad Sci U S A (2007) 1.62
Using itraconazole to clear Batrachochytrium dendrobatidis infection, and subsequent depigmentation of Alytes muletensis tadpoles. Dis Aquat Organ (2009) 1.38
Fungicide risk assessment for aquatic ecosystems: importance of interspecific variation, toxic mode of action, and exposure regime. Environ Sci Technol (2009) 1.26
Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. PLoS One (2009) 1.22
Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae. Antimicrob Agents Chemother (2009) 1.19
Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp. J Antimicrob Chemother (2003) 1.11
Fungicide impacts on microbial communities in soils with contrasting management histories. Chemosphere (2007) 1.08
Developing a safe antifungal treatment protocol to eliminate Batrachochytrium dendrobatidis from amphibians. Med Mycol (2010) 1.02
High-throughput screening for fatty acid uptake inhibitors in humanized yeast identifies atypical antipsychotic drugs that cause dyslipidemias. J Lipid Res (2007) 0.94
Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins. Med Mycol (2010) 0.93
Evidence for distinct DNA- and RNA-based mechanisms of 5-fluorouracil cytotoxicity in Saccharomyces cerevisiae. Yeast (2007) 0.92
Studies on the mode of action of 5-fluorocytosine in Aspergillus species. Chemotherapy (1979) 0.89
Chemical decontamination of soil containing Histoplasma capsulatum. Am J Epidemiol (1966) 0.88
Microbial diversity in paleolithic caves: a study case on the phototrophic biofilms of the Cave of Bats (Zuheros, Spain). Microb Ecol (2010) 0.84
Treatment of spontaneous chytridiomycosis in captive amphibians using itraconazole. J Vet Med Sci (2010) 0.83
Impact of biocide treatments on the bacterial communities of the Lascaux Cave. Naturwissenschaften (2009) 0.78
Evaluation of fungicidal efficacy of benzalkonium chloride (Steramina G u.v.) and Virkon-S against Microsporum canis for environmental disinfection. Vet Res Commun (2006) 0.78
Mode of action of 5-fluorocytosine and 5-fluorouracil in dematiaceous fungi. Sabouraudia (1983) 0.78
Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog (2010) 2.67
The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature (2006) 2.61
Validity of messenger RNA expression analyses of human saliva. Clin Cancer Res (2006) 2.46
Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature (2003) 2.28
Morphological and molecular characterizations of psychrophilic fungus Geomyces destructans from New York bats with White Nose Syndrome (WNS). PLoS One (2010) 1.91
Projecting global occurrence of Cryptococcus gattii. Emerg Infect Dis (2010) 1.78
Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence. Cell Cycle (2009) 1.68
p120 catenin regulates lamellipodial dynamics and cell adhesion in cooperation with cortactin. Proc Natl Acad Sci U S A (2007) 1.59
Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia. Development (2004) 1.58
Genotypic characterization of environmental isolates of Cryptococcus gattii from Puerto Rico. Mycopathologia (2010) 1.52
Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev (2002) 1.50
Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res (2007) 1.46
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagn Microbiol Infect Dis (2011) 1.42
A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients. PLoS Pathog (2011) 1.38
Cryptococcus gattii in AIDS patients, southern California. Emerg Infect Dis (2005) 1.34
Gene-environment interaction signatures by quantitative mRNA profiling in exfoliated buccal mucosal cells. Cancer Res (2004) 1.33
Characterization of Cryptococcus neoformans variety gattii SOD2 reveals distinct roles of the two superoxide dismutases in fungal biology and virulence. Mol Microbiol (2005) 1.28
Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York City (Candida Susceptibility Trends Study, 1998 to 1999). Antimicrob Agents Chemother (2002) 1.26
Clonal genotype of Geomyces destructans among bats with White Nose Syndrome, New York, USA. Emerg Infect Dis (2011) 1.25
Characterization of Cu,Zn superoxide dismutase (SOD1) gene knock-out mutant of Cryptococcus neoformans var. gattii: role in biology and virulence. Mol Microbiol (2003) 1.23
Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2. Carcinogenesis (2004) 1.16
Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol (2002) 1.13
Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method. Antimicrob Agents Chemother (2008) 1.11
Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts. Aging Cell (2008) 1.09
Molecular characterization, biofilm analysis and experimental biofouling study of Fusarium isolates from recent cases of fungal keratitis in New York State. BMC Ophthalmol (2007) 1.06
Phase I and II carcinogen metabolism gene expression in human lung tissue and tumors. Clin Cancer Res (2003) 1.04
Clonal spread of Geomyces destructans among bats, midwestern and southern United States. Emerg Infect Dis (2012) 1.03
Antifungal susceptibility profiles of Coccidioides immitis and Coccidioides posadasii from endemic and non-endemic areas. Mycopathologia (2007) 1.02
Transcription factor STE12alpha has distinct roles in morphogenesis, virulence, and ecological fitness of the primary pathogenic yeast Cryptococcus gattii. Eukaryot Cell (2006) 1.01
Disease surveillance in recombining pathogens: multilocus genotypes identify sources of human Coccidioides infections. Proc Natl Acad Sci U S A (2002) 1.01
Arthrographis keratitis mimicking acanthamoeba keratitis. Cornea (2004) 0.99
Proficiency testing program for clinical laboratories performing antifungal susceptibility testing of pathogenic yeast species. J Clin Microbiol (2003) 0.98
Extracellular fibrils of pathogenic yeast Cryptococcus gattii are important for ecological niche, murine virulence and human neutrophil interactions. PLoS One (2010) 0.98
Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia. J Clin Microbiol (2009) 0.97
The Ess1 prolyl isomerase is required for growth and morphogenetic switching in Candida albicans. Genetics (2002) 0.96
Identification and phylogenetic analysis of a glucose transporter gene family from the human pathogenic yeast Candida albicans. J Mol Evol (2002) 0.96
Chronic rhinofacial mucormycosis caused by Mucor irregularis (Rhizomucor variabilis) in India. J Clin Microbiol (2011) 0.95
Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells. PLoS One (2011) 0.92
Identification and handling of artifactual gene expression profiles emerging in microarray hybridization experiments. Nucleic Acids Res (2004) 0.91
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells. Mol Cancer (2010) 0.91
Identification of endogenous Coccidioides posadasii contamination of commercial primary rhesus monkey kidney cells. J Clin Microbiol (2013) 0.90
The structure of the Candida albicans Ess1 prolyl isomerase reveals a well-ordered linker that restricts domain mobility. Biochemistry (2005) 0.90
Selection of optimal host strain for molecular pathogenesis studies on Cryptococcus gattii. Mycopathologia (2005) 0.90
Genomic organization and expression of 23 new genes from MATalpha locus of Cryptococcus neoformans var. gattii. Biochem Biophys Res Commun (2005) 0.89
Rapid real-time PCR assay for culture and tissue identification of Geomyces destructans: the etiologic agent of bat geomycosis (white nose syndrome). Mycopathologia (2011) 0.88
Flow cytometry antifungal susceptibility testing of Aspergillus fumigatus and comparison of mode of action of voriconazole vis-à-vis amphotericin B and itraconazole. Antimicrob Agents Chemother (2003) 0.87
Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer. Curr Cancer Drug Targets (2015) 0.86
Precursor of brain-derived neurotrophic factor (proBDNF) forms a complex with Huntingtin-associated protein-1 (HAP1) and sortilin that modulates proBDNF trafficking, degradation, and processing. J Biol Chem (2011) 0.86
The Ess1 prolyl isomerase is dispensable for growth but required for virulence in Cryptococcus neoformans. Microbiology (2005) 0.86
Call for a California coccidioidomycosis consortium to face the top ten challenges posed by a recalcitrant regional disease. Mycopathologia (2014) 0.85
Draft Genome Sequences of Human Pathogenic Fungus Geomyces pannorum Sensu Lato and Bat White Nose Syndrome Pathogen Geomyces (Pseudogymnoascus) destructans. Genome Announc (2013) 0.84
Successful surgical intervention for the management of endocarditis due to multidrug resistant Candida parapsilosis: case report and literature review. Mycopathologia (2011) 0.84
Real-time PCR assay for identification of Blastomyces dermatitidis in culture and in tissue. J Clin Microbiol (2012) 0.84
Paracrine Hedgehog increases the steroidogenic potential of prostate stromal cells in a Gli-dependent manner. Prostate (2011) 0.82
Use of paraffin-embedded tissue for identification of Saccharomyces cerevisiae in a baker's lung nodule by fungal PCR and nucleotide sequencing. J Clin Microbiol (2004) 0.82
Development and validation of the simplified Chinese version of EORTC QLQ-H&N35 for patients with head and neck cancer. Support Care Cancer (2011) 0.81
Shiga Toxin 1-Producing Shigella sonnei Infections, California, United States, 2014-2015. Emerg Infect Dis (2016) 0.81
Taxonomy of medically important fungi in the molecular era. Lancet Infect Dis (2013) 0.81
Editorial: dermatophytes and dermatophytoses: a reappraisal for the twenty-first century. Mycopathologia (2008) 0.80
Application of fluorescent probes to study structural changes in Aspergillus fumigatus exposed to amphotericin B, itraconazole, and voriconazole. Mycopathologia (2006) 0.78
A centennial: discovery of Paracoccidioides brasiliensis. Mycopathologia (2008) 0.78
[Clinical study on cytokine induced killer cells therapy to laryngeal cancer after radiotherapy]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2011) 0.76
The 3 prime paradigm of the miR-200 family and other microRNAs. Epigenetics (2011) 0.76
[The expression and significance of hypoxia inducible factor-1alpha and microvessel density in human nasopharyngeal carcinoma]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2008) 0.76
Clinical significance of joint detection of CD44v6 and CD62P in nasopharyngeal carcinoma. Onkologie (2013) 0.76
Editorial: What is in a name? A proposal to use geomycosis instead of White Nose Syndrome (WNS) to describe bat infection caused by Geomyces destructans. Mycopathologia (2011) 0.76
An efficient method for homologous gene reconstitution in Cryptococcus gattii using URA5 auxotrophic marker. Mycopathologia (2006) 0.76
The presence of 3-hydroxy oxylipins in pathogenic microbes. Prostaglandins Other Lipid Mediat (2011) 0.75
Role of Ess1 in growth, morphogenetic switching, and RNA polymerase II transcription in Candida albicans. PLoS One (2013) 0.75
Evaluations of shorter exposures of contact lens cleaning solutions against Fusarium oxysporum species complex and Fusarium solani species complex to simulate inappropriate usage. Antimicrob Agents Chemother (2011) 0.75
Cryptococcus and cryptococcosis in the twenty-first century. Mycopathologia (2012) 0.75
Evaluation of new medium for identification of dermatophytes and primary dimorphic pathogens. J Clin Microbiol (2003) 0.75
[Combined application the siRNA target for Hif-lα and Survivin gene to human NPC CNE-2 cell and its effects on the proliferation and cycle of this cell]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2014) 0.75
[Effects of the inhibition and apoptosis by shRNA mediated survivin gene silencing in xenograft tumor of nasopharyngeal carcinoma cell CNE-2]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2013) 0.75
[Study on the relationship among the projective positions of interior laryngeal structure on thyroid ala]. Lin Chuang Er Bi Yan Hou Ke Za Zhi (2006) 0.75
Development and validation of the system of quality of life instruments for cancer patients: head and neck cancer (QLICP-HN). Oral Oncol (2012) 0.75
[Study on the Photo-thermal Effect of Gold Nanorods Irradiated with Near Infrared Region Laser in Different Conditions]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi (2015) 0.75
[Expression of EGFR about different region tissues and its relationship with histological differentiation in laryngeal carcinoma]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2012) 0.75
Prolonged candidemia in patients with cancer. Clin Infect Dis (2002) 0.75
[The study on the microsurgical anatomy of maxillary sinus approach pterygopalatine fossa]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2007) 0.75
[Treatment and prognosis of squamous cell carcinoma of thyroid]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2010) 0.75
[Detection and clinical significance of vascular endothelium growth factor and microvessel density in patients with nasopharyngeal carcinoma]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2012) 0.75